Recent Updates
Recently added Catalysts
CLLS Positive Sentiment

CELLECTIS

Key Takeaway: Cellectis held its annual shareholders meeting, during which all ordinary and extraordinary resolutions were overwhelmingly approved by shareholders. Significant resolutions included the approval of financial statements for the fiscal year ended December 31, 2024, and various authorizations for capital increases and share buybacks. The shareholder vote demonstrated strong support, with most resolutions passing with over 99% approval. This suggests robust confidence in the company’s strategic direction and governance.
Price reaction · baseline $1.5 (2025-06-25 close) · hit after-hours · clean, no other CLLS news in the window
day 0 close · peak
-0.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Overwhelming approval of financial statements.
  • Successful appointment of new board members.
  • Authorization for share buybacks and issue of new securities.
  • High percentage of votes in favor indicates strong shareholder support.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+13%
120-day peak, hindsight
Typical move
4.6%
average across 4 past catalysts
Lead asset
UCART22
Phase 1 · B-cell Acute Lymphoblastic Leukemia

Full Press Release Details

CELLECTIS ANNUAL SHAREHOLDERS MEETING
Ordinary Resolutions
N Resolution Result For Against Vote withhold Total votes Shares represented by the votes cast Percentage of the share capital represented by the votes cast Out of voting rights Null voting rights Quorum
Votes % Votes % Votes %
1 approval of the annual financial statements for the financial year ended December 31. 2024
1 Carried 52 525 477 99.88 % 62 466 0.12 % 28 629 52 587 943 46 990 754 46.854 % 0 0 57.102 %
2 approval of the consolidated financial statements for the financial year ended December 31. 2024
2 Carried 52 529 012 99.88 % 63 172 0.12 % 24 388 52 592 184 46 990 754 46.854 % 0 0 57.102 %
3 allocation of the results for the financial year ended December 31. 2024
3 Carried 52 536 498 99.88 % 63 177 0.12 % 16 897 52 599 675 46 990 754 46.854 % 0 0 57.102 %
4 allocation of losses carried forward to the share premium account
4 Carried 52 539 884 99.88 % 64 206 0.12 % 12 482 52 604 090 46 990 754 46.854 % 0 0 57.102 %
5 review of the agreements considered in articles L. 225-38 et seq. of the French Commercial Code (financing agreements with Bpifrance)
5 Carried 43 292 348 99.86 % 62 183 0.14 % 9 294 43 354 531 41 117 507 40.998 % 9 252 747 0 57.102 %
6 renewal of the appointment of Mr. Donald Bergstrom as a member of the board of directors
6 Carried 51 136 787 97.20 % 1 470 494 2.80 % 9 291 52 607 281 46 990 754 46.854 % 0 0 57.102 %
CELLECTIS ANNUAL SHAREHOLDERS MEETING
Ordinary Resolutions
N Resolution Result For Against Vote withhold Total votes Shares represented by the votes cast Percentage of the share capital represented by the votes cast Out of voting rights Null voting rights Quorum
Votes % Votes % Votes %
7 appointment of a new director (Mr. Andr Muller)
7 Carried 51 369 389 97.65 % 1 237 892 2.35 % 9 291 52 607 281 46 990 754 46.854 % 0 0 57.102 %
8 authorization to the Board of Directors to buy back shares of the Company
8 Carried 52 451 279 99.71 % 150 602 0.29 % 14 691 52 601 881 46 990 754 46.854 % 0 0 57.102 %
CELLECTIS ANNUAL SHAREHOLDERS MEETING
Extraordinary Resolutions
N Resolution Result For Against Vote withhold Total votes Shares represented by the votes cast Percentage of the share capital represented by the votes cast Out of voting rights Null voting rights Quorum
Votes % Votes % Votes %
9 authorization to be granted to the Board of Directors to reduce the share capital by cancelling shares under the authorization for to buy back its own shares
9 Carried 52 347 621 99.52 % 252 904 0.48 % 16 047 52 600 525 46 990 754 46.854 % 0 0 57.102 %
10 delegation of authority to be granted to the Board of Directors to increase the share capital immediately or in the future by issuing ordinary shares and/or any securities. with cancellation of shareholders' preferential subscription rights in favor of a category of persons meeting specified characteristics (investors with experience in the health or biotech sector)
10 Carried 52 342 540 99.51 % 257 564 0.49 % 16 468 52 600 104 46 990 754 46.854 % 0 0 57.102 %
11 delegation of authority to be granted to the Board of Directors to increase the share capital immediately or in the future by issuing ordinary shares or any securities. with cancellation of shareholders' preferential subscription rights in favor of a category of persons meeting specified characteristics (credit institutions. investment services providers or members of an investment pool guaranteeing the completion of the considered issue)
11 Carried 52 339 570 99.51 % 257 346 0.49 % 19 656 52 596 916 46 990 754 46.854 % 0 0 57.102 %
12 delegation of authority to be granted to the Board of Directors to increase the share capital immediately or in the future by issuing ordinary shares or any other securities. with cancellation of shareholders' preferential subscription rights in favor of a category of persons meeting specified characteristics (industrial companies. institutions or entities active in the health or biotechnology sector)
12 Carried 52 328 269 99.48 % 271 840 0.52 % 16 463 52 600 109 46 990 754 46.854 % 0 0 57.102 %
13 delegation of authority to be granted to the Board of Directors to increase the share capital by issuing ordinary shares or any other securities with cancellation of shareholders' preferential subscription rights in favor of a category of persons meeting specified characteristics in the framework of an equity or bond financing agreement
13 Carried 52 329 025 99.51 % 257 084 0.49 % 30 463 52 586 109 46 990 754 46.854 % 0 0 57.102 %
14 delegation of authority to be granted to the Board of Directors to increase the share capital immediately or in the future by issuing ordinary shares or any other securities giving access to the share capital. with the shareholders' preferential subscription rights maintained
14 Carried 52 355 773 99.53 % 248 737 0.47 % 12 062 52 604 510 46 990 754 46.854 % 0 0 57.102 %
CELLECTIS ANNUAL SHAREHOLDERS MEETING
Extraordinary Resolutions
N Resolution Result For Against Vote withhold Total votes Shares represented by the votes cast Percentage of the share capital represented by the votes cast Out of voting rights Null voting rights Quorum
Votes % Votes % Votes %
15 delegation of authority to be granted to the Board of Directors to increase the share capital immediately or in the future through the issue of ordinary shares or any securities. with cancellation of the shareholders' preferential subscription rights by way of a public offering (other than the offers referred to in paragraph 1 of Article L. 411-2 of the French Monetary and Financial Code)
15 Carried 51 307 316 97.53 % 1 297 187 2.47 % 12 069 52 604 503 46 990 754 46.854 % 0 0 57.102 %
16 delegation of authority to be granted to the Board of Directors to increase the share capital immediately or in the future through the issue of ordinary shares or any securities. with cancellation of the shareholders' preferential subscription rights by way of an offer referred to in paragraph 1 of Article L. 411-2 of the French Monetary and Financial Code
16 Carried 52 346 469 99.51 % 258 040 0.49 % 12 063 52 604 509 46 990 754 46.854 % 0 0 57.102 %
17 delegation of authority to be granted to the Board of Directors to increase the number of each of shares to be issued in the event of a capital increase with or without preferential subscription rights
17 Carried 51 306 006 97.56 % 1 284 203 2.44 % 26 363 52 590 209 46 990 754 46.854 % 0 0 57.102 %
18 overall limitations on the amount of issues made under the Tenth resolution to the Seventeenth resolution aforementioned
18 Carried 52 491 173 99.81 % 99 331 0.19 % 26 068 52 590 504 46 990 754 46.854 % 0 0 57.102 %
19 delegation of authority to be granted to the board of directors to increase the share capital by incorporation of premiums. reserves. profits or other
19 Carried 52 502 351 99.81 % 102 156 0.19 % 12 065 52 604 507 46 990 754 46.854 % 0 0 57.102 %
20 authorization to be granted to the Board of Directors to grant options to subscribe for or purchase ordinary shares in the Company. entailing a waiver by the shareholders of their preferential subscription rights
20 Carried 43 106 901 99.44 % 244 865 0.56 % 9 264 806 43 351 766 46 990 754 46.854 % 0 0 57.102 %
CELLECTIS ANNUAL SHAREHOLDERS MEETING
Extraordinary Resolutions
N Resolution Result For Against Vote withhold Total votes Shares represented by the votes cast Percentage of the share capital represented by the votes cast Out of voting rights Null voting rights Quorum
Votes % Votes % Votes %
21 authorization to be granted to the Board of Directors to proceed with free allocations of ordinary shares of the Company. to the benefit of employees and/or corporate officers of the Company and its subsidiaries. entailing the waiver by the shareholders of their preferential subscription rights
21 Carried 43 094 306 99.41 % 257 460 0.59 % 9 264 806 43 351 766 46 990 754 46.854 % 0 0 57.102 %
22 delegation of authority to be granted to the board of directors to issue warrants giving the right to subscribe ordinary shares of the Company cancellation of the preferential right of subscription to the benefit of a category of persons meeting specific characteristics (persons who have entered into a service or consultant contract with the Company or with one of its subsidiaries)
22 Carried 43 098 880 99.42 % 253 300 0.58 % 9 264 392 43 352 180 46 990 754 46.854 % 0 0 57.102 %
23 determination of the total amount of the capital increases that may be carried out by virtue of the aforementioned authorization to grant options to subscribe for or purchase shares and the aforementioned authorization to grant free shares
23 Carried 52 517 949 99.83 % 86 973 0.17 % 11 650 52 604 922 46 990 754 46.854 % 0 0 57.102 %
24 delegation of authority to be granted to the Board of Directors to proceed with an increase in the share capital. the subscription of which would be reserved for the members of a company savings plan established pursuant to Articles L. 3332-1 et seq. of the Labor Code
24 Rejected 5 226 316 10.92 % 42 653 391 89.08 % 4 736 865 47 879 707 46 990 754 46.854 % 0 0 57.102 %
25 amendment of Article 12 of the articles of association meeting of the Board of Directors
25 Carried 52 506 572 99.83 % 88 887 0.17 % 21 113 52 595 459 46 990 754 46.854 % 0 0 57.102 %
26 amendment of Article 18 of the articles of association relating to shareholders meetings
26 Carried 50 532 855 96.07 % 2 066 398 3.93 % 17 319 52 599 253 46 990 754 46.854 % 0 0 57.102 %

Frequently Asked Questions

What was the result of approving the annual financial statements?

The resolution was carried with 99.88% approval.

How many shares were represented during the meeting?

A total of 52,587,943 shares were represented.

Was the appointment of a new director approved?

Yes, the appointment of Mr. Andr Muller was carried with 97.65% votes.

What percentage supported the share buyback authorization?

The authorization to buy back shares received 99.71% support.

How did shareholders respond to free share allocations?

The resolution for free allocations received 99.41% approval.

Last updated: Jun 26, 2025